Related Experiment Video
Updated: Jul 10, 2026
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Unraveling Botulinum Neurotoxin A Light-Chain-Induced Signaling Pathways: A Phosphoproteomic Analysis in a Controlled
Chensi Zhu1, Liangyan Zhang1, Wenjing Yu1
1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China.
Abstract:
Botulinum neurotoxin type A (BoNT/A), among the most potent known toxins, is widely used in cosmetic medicine. However, its toxicity mechanisms remain poorly understood due to a lack of suitable models. Here, we generated a doxycycline (DOX)-inducible Neuro-2a cell line stably expressing the BoNT/A light chain (ALC). ALC expression was confirmed by GFP and FLAG tag antibodies, and its activity was validated through cleavage of the substrate SNAP-25. Using this model, combined with natural toxin infection of cells, phospho-antibody microarray analysis revealed significant alterations in host phosphorylation networks in both ALC-expressing and toxin-infected cells. Among the shared phosphorylation changes, 75 proteins showed upregulation, while 27 were downregulated. Upregulated phosphorylation events were enriched in pathways such as PI3K-AKT signaling, EGFR tyrosine kinase inhibitor resistance, and Ras signaling, whereas downregulated events were associated with the ERBB and thyroid hormone signaling pathways. Key alterations were observed in AKT signaling, with protein-protein interaction analysis identifying Hsp90ab1 and Map2k1 as central hub molecules for upregulated and downregulated proteins, respectively. This study establishes a robust Neuro-2a-based model system to study BoNT/A toxicity and provides insights into toxin-induced phosphorylation network changes, offering a valuable platform for therapeutic screening and mechanistic exploration.
Insights
A new cell model for studying Botulinum neurotoxin type A (BoNT/A) reveals significant changes in host cell phosphorylation networks. This research advances understanding of BoNT/A toxicity mechanisms and aids therapeutic development.
Area of Science:
- Neuroscience
- Cell Biology
- Toxicology
Background:
- Botulinum neurotoxin type A (BoNT/A) is a potent toxin used in cosmetic medicine.
- Understanding BoNT/A toxicity mechanisms is limited by the lack of suitable experimental models.
Purpose of the Study:
- To develop a novel cell model for studying BoNT/A toxicity.
- To investigate the impact of BoNT/A on host cell phosphorylation networks.
Main Methods:
- Generation of a doxycycline-inducible Neuro-2a cell line expressing the BoNT/A light chain (ALC).
- Validation of ALC expression and activity via GFP/FLAG tags and SNAP-25 cleavage.
- Phospho-antibody microarray analysis of cells expressing ALC and cells infected with natural toxin.
Main Results:
- Significant alterations in host phosphorylation networks were identified in both ALC-expressing and toxin-infected cells.
- 75 proteins showed upregulated phosphorylation, enriched in PI3K-AKT, EGFR, and Ras signaling pathways.
- 27 proteins showed downregulated phosphorylation, associated with ERBB and thyroid hormone signaling pathways, with key changes in AKT signaling.
Conclusions:
- A robust Neuro-2a-based model system for BoNT/A toxicity studies has been established.
- The study provides insights into toxin-induced phosphorylation network changes.
- This model serves as a valuable platform for therapeutic screening and mechanistic exploration of BoNT/A.
